SCHEMBL2409644

SCHEMBL2409644

COC(=O)C(O)CCC(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TET2 Q6N021 3/20 0.56
KDM2A Q9Y2K7 3/20 0.56
KDM4A O75164 2/20 0.56
KDM4C Q9H3R0 2/20 0.56
TET3 O43151 1/20 0.56
GABRP O00591 2/20 0.43
GABRD O14764 2/20 0.43
GABRA1 P14867 2/20 0.43
GABRB1 P18505 2/20 0.43
GABRG2 P18507 2/20 0.43
GABRB3 P28472 2/20 0.43
GABRA5 P31644 2/20 0.43
GABRA3 P34903 2/20 0.43
GABRA2 P47869 2/20 0.43
GABRB2 P47870 2/20 0.43
GABRA4 P48169 2/20 0.43
GABRE P78334 2/20 0.43
GABRA6 Q16445 2/20 0.43
GABRG1 Q8N1C3 2/20 0.43
GABRG3 Q99928 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4748334 0.87 TSHR (0.48) TET2KDM2AKDM4AKDM4CTET3
SCHEMBL17055793 0.82 TSHR (0.52) TSHRSLC1A1CA1CA2KDM4E
SCHEMBL4057765 0.82 TSHR (0.52) TSHRSLC1A1CA1CA2KDM4E
SCHEMBL14436811 0.82 TSHR (0.52) TSHRSLC1A1CA1CA2KDM4E
SCHEMBL1296430 0.81 TET2 (0.61) TET2KDM2AKDM4AKDM4CTET3
SCHEMBL27642794 0.80 TET2 (0.54) TET2KDM2AKDM4AKDM4CTET3
SCHEMBL2821456 0.79 FOLH1 (0.50) TET2KDM2AKDM4AKDM4CTET3
SCHEMBL712283 0.77 CYP1A2 (0.60) TET2KDM2AKDM4AKDM4CTET3
SCHEMBL10254859 0.77 CYP1A2 (0.60) TET2KDM2AKDM4AKDM4CTET3
SCHEMBL27465091 0.77 TET2 (0.56) TET2KDM2AKDM4AKDM4CTET3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011106546-A1 A PROCESS FOR THE PREPARATION OF ROSUVASTATIN INTERMEDIATE TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2011-09-01 WO disclosed
EP-1985300-A2 A compound for re-equilibrating the intestinal bacterial flora with an antidiarrhoeic, anti-inflammatory and lentive activity against lactose and lactose derivative intolerances Farmaceutici S.R.L. (IT) 2008-10-29 EP disclosed
US-6215016-B1 HEMATOPOIETIC AGENTS; PREVENTING CYTOPENIA TORAY INDUSTRIES, INC. (JP) 2001-04-10 US disclosed
EP-0841063-A1 KETONE DERIVATIVES AND MEDICINAL USE THEREOF TORAY INDUSTRIES, INC. (JP) 1998-05-13 EP disclosed